R.K.S. RathoreTop StoriesRadiation Oncology/TherapySingle-fraction SBRT a valid option for localized prostate cancerEstimated three-year biochemical relapse-free survival was 92.9%.Clinical NewsWHO: Europe's healthcare systems face "permacrisis"MRIGerman MRI concept aims to transform pediatric imagingUltrasoundVideo: Dr. Alba Pugliesi on what keeps her dreams bigClinical NewsUEMS: Ukraine health leaders: Resiliency should never mean isolation